Premium
Low infectious complications in segmental living related small bowel transplantation in adults
Author(s) -
Cicalese Luca,
Sileri Pierpaolo,
Asolati Massimo,
Rastellini Cristiana,
Abcarian Herand,
Benedetti Enrico
Publication year - 2000
Publication title -
clinical transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 76
eISSN - 1399-0012
pISSN - 0902-0063
DOI - 10.1034/j.1399-0012.2000.140609.x
Subject(s) - medicine , immunosuppression , transplantation , surgery , gastroenterology , azathioprine , tacrolimus , disease
Clinical small bowel transplantation (SBTx) has been associated with a high rate of infectious complications. Laparotomy, preservation injury, abnormal motility, lymphatic disruption, aberrant systemic venous drainage, rejection and antibiotic therapy could all be implicated in the etiology of these complications. In addition to the underlying disease, total parental nutrition could determine infections and liver impairment. Recently, standardized techniques for segmental living related SBTx (LR‐SBTx) have been developed. This technique allows reduction of some of these factors, thus resulting in a reduced incidence of infections. We report the infectious complications observed in 3 patients with short bowel syndrome treated with LR‐SBTx at our institution. A segment of 180–200 cm of ileum was transplanted with a neglectably short cold ischemia time (CIT). The donor bowel was decontaminated. Oral tacrolimus, prednisone and IV induction with ATG were used for immunosuppression. Blood, stool, urine, sputum and peritoneal fluids were collected and cultured as a routine surveillance. All recipients are alive with a current follow‐up time up to 21 months. No bacterial infections were observed during the post‐transplant period. One patient developed cytomegalovirus (CMV) enteritis 4 months after LR‐SBTx and was treated successfully with IV ganciclovir. In our limited experience, LR‐SBTx is associated with a low infection rate. This could be due to optimal graft decontamination, short CIT and to the reduced incidence of rejection and lower immunosuppression used in this immunologically well‐matched combination.